Skip to main content

Alfuzosin (International)

In the US, Alfuzosin (alfuzosin systemic) is a member of the drug class alpha blockers and is used to treat Benign Prostatic Hyperplasia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G04CA01

CAS registry number (Chemical Abstracts Service)

0081403-80-7

Chemical Formula

C19-H27-N5-O4

Molecular Weight

389

Therapeutic Categories

α₁-adrenoceptor antagonist (α₁-blocker)

Treatment of symptoms of benign prostatic hyperplasia

Chemical Name

(±)-N-[3-[(4-amino-6,7-dimetoxy-2-quinazolinyl)metylamino]propyl]tetrahydro-2-furamide (WHO)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs